RGNX – REGENXBIO Inc.
REGENXBIO Inc.RGNX
$9.61Name : REGENXBIO Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $482,041,440.00
EPSttm : -3.09
REGENXBIO Inc.
$9.61
14.95%$1.25Float Short %
13.85
Margin Of Safety %
Put/Call OI Ratio
0.34
EPS Next Q Diff
0.96
EPS Last/This Y
4.82
EPS This/Next Y
-1.75
Price
9.6
Target Price
33.15
Analyst Recom
1.38
Performance Q
51.58
Relative Volume
1.66
Beta
1.09
Ticker: RGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | RGNX | 7.15 | 0.31 | 0.05 | 4246 |
| 2025-05-09 | RGNX | 7.53 | 0.31 | 0.02 | 4269 |
| 2025-05-12 | RGNX | 7.97 | 0.31 | 0.01 | 4293 |
| 2025-05-13 | RGNX | 8.19 | 0.29 | 0.00 | 4434 |
| 2025-05-14 | RGNX | 8.33 | 0.29 | 0.07 | 4466 |
| 2025-05-15 | RGNX | 8.66 | 0.29 | 0.08 | 4474 |
| 2025-05-16 | RGNX | 8.91 | 0.29 | 0.72 | 4426 |
| 2025-05-19 | RGNX | 9.81 | 0.45 | 0.06 | 3202 |
| 2025-05-20 | RGNX | 9.99 | 0.36 | 0.01 | 3911 |
| 2025-05-21 | RGNX | 9.64 | 0.35 | 0.00 | 4053 |
| 2025-05-22 | RGNX | 9.86 | 0.35 | 0.15 | 4055 |
| 2025-05-23 | RGNX | 9.73 | 0.39 | 0.07 | 3838 |
| 2025-05-27 | RGNX | 9.08 | 0.36 | 0.02 | 4109 |
| 2025-05-28 | RGNX | 8.53 | 0.39 | 0.14 | 3956 |
| 2025-05-29 | RGNX | 8.96 | 0.39 | 0.00 | 3948 |
| 2025-05-30 | RGNX | 8.85 | 0.36 | 0.00 | 4176 |
| 2025-06-02 | RGNX | 10.33 | 0.35 | 0.03 | 4238 |
| 2025-06-03 | RGNX | 10.14 | 0.34 | 0.06 | 4391 |
| 2025-06-04 | RGNX | 10.09 | 0.34 | 0.00 | 4459 |
| 2025-06-05 | RGNX | 8.36 | 0.34 | 0.42 | 4434 |
| 2025-06-06 | RGNX | 9.59 | 0.34 | 0.02 | 4794 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | RGNX | 7.14 | 136.3 | 328.2 | -0.98 |
| 2025-05-09 | RGNX | 7.52 | 136.3 | 342.0 | -0.98 |
| 2025-05-12 | RGNX | 7.97 | 136.3 | 343.4 | -0.98 |
| 2025-05-13 | RGNX | 8.18 | 136.3 | 336.1 | -0.98 |
| 2025-05-14 | RGNX | 8.34 | 136.3 | 335.0 | -0.98 |
| 2025-05-15 | RGNX | 8.66 | 136.3 | 227.7 | -0.98 |
| 2025-05-16 | RGNX | 8.90 | 136.3 | 226.3 | 0.16 |
| 2025-05-19 | RGNX | 9.79 | -9.7 | 236.3 | 0.16 |
| 2025-05-20 | RGNX | 10.00 | -9.7 | 224.9 | 0.16 |
| 2025-05-21 | RGNX | 9.64 | -9.7 | 217.0 | 0.16 |
| 2025-05-22 | RGNX | 9.85 | -9.7 | 224.8 | 0.16 |
| 2025-05-23 | RGNX | 9.71 | -9.7 | 219.8 | 0.16 |
| 2025-05-27 | RGNX | 9.07 | -0.4 | 213.0 | 0.23 |
| 2025-05-28 | RGNX | 8.53 | -0.4 | 213.3 | 0.23 |
| 2025-05-29 | RGNX | 8.97 | -0.4 | 229.4 | 0.23 |
| 2025-05-30 | RGNX | 8.85 | -0.4 | 219.8 | 0.23 |
| 2025-06-02 | RGNX | 10.35 | -0.4 | 246.1 | 0.23 |
| 2025-06-03 | RGNX | 10.13 | -0.4 | 219.2 | 0.23 |
| 2025-06-04 | RGNX | 10.09 | -0.4 | 221.4 | 0.23 |
| 2025-06-05 | RGNX | 8.36 | -0.4 | 199.2 | 0.23 |
| 2025-06-06 | RGNX | 9.60 | -0.4 | 244.8 | 0.23 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | RGNX | 0.00 | -1.36 | 11.61 |
| 2025-05-09 | RGNX | 0.00 | -1.36 | 11.61 |
| 2025-05-12 | RGNX | 0.00 | 3.05 | 11.43 |
| 2025-05-13 | RGNX | 0.00 | 3.05 | 11.43 |
| 2025-05-14 | RGNX | 0.00 | 3.05 | 11.43 |
| 2025-05-15 | RGNX | -0.41 | 3.05 | 11.45 |
| 2025-05-16 | RGNX | -0.41 | 3.05 | 11.45 |
| 2025-05-19 | RGNX | -0.44 | 7.19 | 11.35 |
| 2025-05-20 | RGNX | -0.44 | 7.19 | 11.35 |
| 2025-05-21 | RGNX | -0.44 | 7.19 | 11.35 |
| 2025-05-22 | RGNX | -0.44 | 7.19 | 11.35 |
| 2025-05-23 | RGNX | -0.44 | 7.19 | 11.35 |
| 2025-05-27 | RGNX | -0.44 | 1.56 | 11.35 |
| 2025-05-28 | RGNX | -0.44 | 1.56 | 13.85 |
| 2025-05-29 | RGNX | -0.44 | 1.56 | 13.85 |
| 2025-05-30 | RGNX | -0.44 | 1.56 | 13.85 |
| 2025-06-02 | RGNX | -0.44 | 2.31 | 13.85 |
| 2025-06-03 | RGNX | -0.44 | 2.31 | 13.85 |
| 2025-06-04 | RGNX | -0.44 | 2.31 | 13.85 |
| 2025-06-05 | RGNX | -0.44 | 2.31 | 13.85 |
| 2025-06-06 | RGNX | -0.44 | 2.31 | 13.85 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.12
Avg. EPS Est. Current Quarter
-1.05
Avg. EPS Est. Next Quarter
1.08
Insider Transactions
-0.44
Institutional Transactions
2.31
Beta
1.09
Average Sales Estimate Current Quarter
40
Average Sales Estimate Next Quarter
110
Fair Value
Quality Score
44
Growth Score
34
Sentiment Score
1
Actual DrawDown %
80.9
Max Drawdown 5-Year %
-89.4
Target Price
33.15
P/E
Forward P/E
PEG
P/S
3.08
P/B
1.76
P/Free Cash Flow
EPS
-3.14
Average EPS Est. Cur. Y
0.23
EPS Next Y. (Est.)
-1.52
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-100.62
Relative Volume
1.66
Return on Equity vs Sector %
-81.6
Return on Equity vs Industry %
-63.6
EPS 1 7Days Diff
EPS 1 30Days Diff
1.21
EBIT Estimation
244.8
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading